Janus kinase (JAK) inhibitors can quickly and effectively manage ulcerative colitis (UC), especially when more conventional treatments haven’t worked. UC is a type of inflammatory bowel disease ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN FRANCISCO -- Janus kinase (JAK) inhibitors appeared to be a safe, effective option for treating inflammatory bowel ...

Newer drugs called JAK inhibitors prevent inflammation from inside the cells. Unlike other biological RA treatments, which may need to be injected into the skin, JAK inhibitors can be taken as a pill.

JAK inhibitors, a new class of tsDMARDs, have shown superior efficacy in RCTs for RA compared to other biologics. Real-world studies highlight JAK inhibitors' benefits in clinical disease activity ...

Janus kinase inhibitors are an incredibly important, new tool that have exemplified both high efficacy and safety, according to a speaker at South Beach Symposium.In an interview with Healio, ...

More research on outcomes of pregnancies exposed to JAK inhibitors, they added, “may provide more nuanced guidelines based on higher levels of evidence and risk-benefit analysis of pregnant ...

Targeted drugs for rheumatoid arthritis (RA) are not created equal when it comes to pain relief, a retrospective study from ...

In May last year, the FDA approved Incyte’s Jakafi (ruxolitinib), also a JAK inhibitor, for steroid-refractory ... the Biden administration has dropped the list of the next 15 drugs to be ...

WASHINGTON -- Patients taking Janus kinase (JAK) inhibitors for rheumatoid arthritis (RA) may not have to worry so much about increased cardiovascular risk -- if they're taking statins ...